EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical outcomes and prognostic factors of adjuvant radiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study

Keisuke Tsuchida iD, Ken Ando, Noriyuki Okonogi iD, Mayuyo Mori, Masato Nishimura, Kenta Yoshida, Norihiro Sugino, Munetaka Takekuma iD, Aikou Okamoto, Tatsuya Ohno iD, Shin Nishio iD

Journal of Radiation Research · 2025

DOI: 10.1093/jrr/rraf050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Radiation Research, 2025. Verfasst von Keisuke Tsuchida und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. Hauptthemen laut MEDLINE: Vulvar Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to analyze the clinical outcomes and prognostic factors of postoperative adjuvant radiotherapy (RT) for vulvar cancer based on a retrospective Japanese nationwide survey. Data were collected from 108 institutions for patients diagnosed with vulvar cancer between January 2001 and December 2010. Patients with histologically confirmed squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma who underwent curative surgery and adjuvant radiotherapy were included in this study. Survival outcomes were estimated using the Kaplan–Meier method, and prognostic factors were analyzed via univariate and multivariate models. A total of 139 patients were included, with a median follow-up of 44 months (range: 3–169). The 5-year overall survival (OS) rates (95% confidence interval [CI]) for stages I, II, III, and IV were 71.8% (50.8–92.8%), 61.3% (40.1–82.5%), 58.0% (45.8–70.2%), and 47.3% (27.5–67.1%), respectively. The corresponding 5-year cause-specific survival (CSS) rates (95% CI) for stages I, II, III, and IV were 71.8% (50.8–92.8%), 73.4% (53.0–93.8%), 62.2% (50.0–74.4%), and 47.3% (27.5–67.1%). Multivariate analysis identified age ≥70 years as an independent adverse prognostic factor for OS (hazard ratio [HR]: 1.848; 95% CI: 1.039–3.281; P = 0.042), while the presence of ≥2 inguinofemoral lymph node metastases was significantly associated with poorer CSS (HR: 2.179; 95% CI: 1.109–4.280; P = 0.030). Our analysis identified advanced age and a higher nodal burden as significant predictors of poorer survival outcomes in patients with vulvar cancer receiving postoperative adjuvant RT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vulvar NeoplasmsHumansFemaleAgedMiddle AgedRadiotherapy, AdjuvantPrognosisJapanAged, 80 and overTreatment OutcomeAdultSurveys and QuestionnairesRetrospective StudiesEast Asian People

Stichwörter der Autor:innen

lymph node metastasisnationwide studysdjuvant radiotherapysurgeryvulvar cancer

Autor:innen und Institutionen

  • Department of Radiation Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
  • Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
  • Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Department of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  • Department of Obstetrics and Gynecology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.

ORCID-Profile: Keisuke Tsuchida, Noriyuki Okonogi, Munetaka Takekuma, Tatsuya Ohno, Shin Nishio

Förderung

  • JSPS

Zitieren

APA

Tsuchida, K., Ando, K., Okonogi, N., Mori, M., Nishimura, M., Yoshida, K., Sugino, N., Takekuma, M., Okamoto, A., Ohno, T., & Nishio, S. (2025). Clinical outcomes and prognostic factors of adjuvant radiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study. Journal of Radiation Research. https://doi.org/10.1093/jrr/rraf050

Vancouver

Tsuchida K, Ando K, Okonogi N, Mori M, Nishimura M, Yoshida K, et al. Clinical outcomes and prognostic factors of adjuvant radiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study. Journal of Radiation Research. 2025. doi:10.1093/jrr/rraf050

BibTeX
@article{Tsuchida2025,
  author = {Tsuchida, Keisuke and Ando, Ken and Okonogi, Noriyuki and Mori, Mayuyo and Nishimura, Masato and Yoshida, Kenta and Sugino, Norihiro and Takekuma, Munetaka and Okamoto, Aikou and Ohno, Tatsuya and Nishio, Shin},
  title = {Clinical outcomes and prognostic factors of adjuvant radiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study},
  journal = {Journal of Radiation Research},
  year = {2025},
  doi = {10.1093/jrr/rraf050}
}
Kostenlos starten →